#BEGIN_DRUGCARD DB01875

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1468-26-4

# ChEBI_ID:
40850

# Chemical_Formula:
C4H2N5O2

# Chemical_IUPAC_Name:
[1,2,3]triazolo[4,5-d]pyrimidine-5,7-dione

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
8-Azaxanthine

# HET_ID:
AZA

# Half_Life:
Not Available

# InChI_Identifier:
Not Available

# InChI_Key:
Not Available

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1875

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
152.091

# Molecular_Weight_Mono:
152.020849333

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1J2G

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-1.6

# Predicted_Water_Solubility:
3.64e+00 g/l

# Primary_Accession_No:
DB01875

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
15113

# PubChem_Substance_ID:
46508460

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00599

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O=C1Nc2nnnc2C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:34 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB048366

# Drug_Target_1_GenBank_ID_Protein:
12082301

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
uao

# Drug_Target_1_Gene_Sequence:
>1509 bp
ATGATGCGATTAAAACAATTAAATGAAATGAGTGCTTCCGAATTTATCCATCTATTAGGA
GGAGTTTTTGAGAATTCATCATGGGTGGCCGAACGAGCAGAACCCAATCGCCCATACTCT
TCCTTTCAATCTCTATATAATAAAATGGTGGAGATTGTCGAAACCGCTTCGGATAACGAA
CAATTAAAATTAATTCAAATGCATCCGCATCTAGGCACCAACGTCAAAATAACCGATTTC
TCTCAAGAGGAACAGAAACATGCCGGATTAAATGAATTAACAAAAGATGAACAGAATCAT
CTCATTTTACTCAACCAAAAATACAAGGATAAATTTGGATTTCCATTTGTAATGGCCGTT
CGAGGAAAAATCAAACAAGAAATTTTTAGAACGATCAAAGAACGATTACAAAATAATCAT
CAAACGGAGTTTAAACAAGCATTGGAAGAAATTAAAAAAATCGCAATGTTTCGTTTGCAA
GAAATATTTCGTGAAGGAGAGAATAATTCGATGACCAAACACAAAGAAAGAGTGATGTAT
TATGGAAAAGGTGACGTATTTGCTTATCGCACCTATTTAAAACCACTTACTGGAGTTAGA
ACGATTCCTGAATCTCCATTTTCCGGTCGAGATCATATTCTTTTTGGAGTAAATGTAAAA
ATCTCAGTAGGAGGAACAAAATTGCTGACCTCCTTTACGAAAGGGGATAACAGCTTAGTC
GTTGCAACAGACTCGATGAAAAACTTTATACAAAAACATTTAGCTAGTTATACAGGAACA
ACGATAGAAGGTTTTTTAGAATATGTAGCTACTTCTTTTTTGAAGAAATATTCTCATATT
GAAAAGATTTCGTTGATAGGAGAGGAAATTCCCTTTGAAACAACTTTTGCAGTAAAGAAT
GGAAATAGAGCAGCTAGTGAGCTAGTATTTAAAAAATCACGAAATGAATATGCCACCGCT
TATTTGAATATGGTTCGTAATGAAGATAACACCCTAAACATTACTGAACAACAAAGCGGA
CTTGCTGGTCTTCAATTAATAAAAGTCAGCGGAAATTCCTTTGTCGGTTTTATTCGTGAC
GAATACACAACTCTTCCAGAGGATTCAAACCGCCCTCTATTTGTTTACTTAAACATCAAA
TGGAAGTACAAAAACACGGAAGACTCATTTGGAACGAATCCAGAAAATTATGTTGCAGCT
GAACAAATTCGCGACATCGCCACTTCCGTATTTCATGAAACCGAGACGCTTTCCATCCAA
CATTTAATTTATTTAATCGGCCGCAGAATATTAGAAAGATTCCCTCAACTTCAAGAAGTT
TACTTCGAATCTCAAAATCATACATGGGATAAAATAGTGGAGGAAATTCCTGAATCAGAA
GGGAAAGTATATACAGAACCGCGACCGCCATATGGATTTCAATGCTTTACTGTCACCCAA
GAAGACTTGCCACACGAAAACATTCTTATGTTCTCTGATGAACCCGATCATAAAGGAGCA
CTTAAATGA

# Drug_Target_1_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_1_General_References:
8907179	Yamamoto K, Kojima Y, Kikuchi T, Shigyo T, Sugihara K, Takashio M, Emi S: Nucleotide sequence of the uricase gene from Bacillus sp. TB-90. J Biochem (Tokyo). 1996 Jan;119(1):80-4.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2399

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
57979

# Drug_Target_1_Name:
Uricase

# Drug_Target_1_Number_of_Residues:
502

# Drug_Target_1_PDB_ID:
1J2G

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01014	Uricase

# Drug_Target_1_Protein_Sequence:
>Uricase
MMRLKQLNEMSASEFIHLLGGVFENSSWVAERAEPNRPYSSFQSLYNKMVEIVETASDNE
QLKLIQMHPHLGTNVKITDFSQEEQKHAGLNELTKDEQNHLILLNQKYKDKFGFPFVMAV
RGKIKQEIFRTIKERLQNNHQTEFKQALEEIKKIAMFRLQEIFREGENNSMTKHKERVMY
YGKGDVFAYRTYLKPLTGVRTIPESPFSGRDHILFGVNVKISVGGTKLLTSFTKGDNSLV
VATDSMKNFIQKHLASYTGTTIEGFLEYVATSFLKKYSHIEKISLIGEEIPFETTFAVKN
GNRAASELVFKKSRNEYATAYLNMVRNEDNTLNITEQQSGLAGLQLIKVSGNSFVGFIRD
EYTTLPEDSNRPLFVYLNIKWKYKNTEDSFGTNPENYVAAEQIRDIATSVFHETETLSIQ
HLIYLIGRRILERFPQLQEVYFESQNHTWDKIVEEIPESEGKVYTEPRPPYGFQCFTVTQ
EDLPHENILMFSDEPDHKGALK

# Drug_Target_1_Reaction:
urate + O2 + H2O = 5-hydroxyisourate + H2O2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the oxidation of uric acid to 5- hydroxyisourate which spontaneously decompose to form allantoin

# Drug_Target_1_SwissProt_ID:
Q45697

# Drug_Target_1_SwissProt_Name:
PUCL_BACSB

# Drug_Target_1_Synonyms:
EC 1.7.3.3
Urate oxidase

# Drug_Target_1_Theoretical_pI:
6.58

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01875
